Gilead Sciences (GILD) EBITDA margin US GAAP (year values)

FY2021 FY2022 FY2023 FY2024 FY2025   LTM ? CAGR 5 years ?
EBITDA margin, % ? 41.5% 32.4% 38.7% 15.4% 46.1%   44.8%  
Changes by years, y/y, % +25pp -9pp +6pp -23pp +31pp     +22.5%

Gilead Sciences. EBITDA margin, %

Gilead Sciences. EBITDA margin, changes, pp

Gilead Sciences (GILD) EBITDA margin US GAAP (quarter values)

FY2025Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2026Q1   LTM ?
EBITDA margin, % ? 39.1% 47.6% 59.0% 38.1% 33.8%   44.8%
Changes by years, y/y, % +92pp +5pp +34pp -3pp -5pp    
Changes by quarters, q/q, % -2pp +9pp +11pp -21pp -4pp    

Gilead Sciences. EBITDA margin, %

Gilead Sciences. EBITDA margin, changes, pp

Gilead Sciences. EBITDA margin, changes, pp